Formulation and Evaluation of Meclizine Hydrochloride Cyclodextrin-Based Mucoadhesive Thermosensitive Nasal In-Situ Gel
DOI:
https://doi.org/10.31351/vol34iss1pp108-121Keywords:
Meclizine HC, in situ nasal gel, poloxamers, mucoadhesive polymerAbstract
Meclizine Hydrochloride (MCZ) is an effective antihistamine for the prevention and treatment of nausea and vomiting, with low oral bioavailability (about 30 to 40%) due to low water solubility. The purpose of the current study was to develop and characterize a thermo-responsive nasal in-situ gel for MCZ. To enhance the solubility of MCZ, an inclusion complex with Hydroxypropyl-β-Cyclodextrin (HP-β-CD) was prepared and characterized. The prepared complex was utilized in the preparation of thermosensitive in situ gels using the cold method. Twelve formulations were developed by employing various concentrations of Poloxamer 407, either alone or in combination with Poloxamer 188. Additionally, hydroxypropyl methylcellulose K4M (HPMC K4M) was incorporated as a mucoadhesive polymer. The prepared formulations were characterized by their appearance, pH value, gelation temperature, mucoadhesive force, gel strength, drug content, and drug release rate. The results showed that as the concentration of poloxamer 188 and HPMC K4M were increased, there was a decrease in gelation temperature, an increase in mucoadhesive strength, and a decrease in the percent drug released. The in-situ gel formulation (F9) with 19 % P407, 3 % P188 and 0.5% HPMC K4M was identified as the optimum formula with gelation temperature of (32.62±0.1 °C), pH value (6.13±0.05), gel strength (39.3 ±0.57 sec), mucoadhesive force (3389.30±0.46 dyne/cm2), and in-vitro drug release of (75.7%) over 6 hours by non-Fickian diffusion mechanism. Owing to these properties the prepared formulation may be used as an effective nasal delivery system for management of nausea and vomiting.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Laffleur F, Bauer B. Progress in nasal drug delivery systems. Int J Pharm. 2021;607:120994.
Zaki NM, Awad GA, Mortada ND, Abd ElHady SS. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Eur J Pharm Sci. 2007;32(4–5):296–307.
Palhal AP. In-situ nasal gel: Modernistic advancement in drug delivery. World J Pharm Res. 2017;6:566–77.
Wang Q, Zuo Z, Cheung CKC, Leung SSY. Updates on thermosensitive hydrogel for nasal, ocular and cutaneous delivery. Int J Pharm. 2019;559:86–101.
Karavasili C, Fatouros DG. Smart materials: In situ gel-forming systems for nasal delivery. Drug Discov Today. 2016;21(1):157–66
Alkufi HK, Kassab HJ. Formulation and evaluation of sustained release sumatriptan mucoadhesive intranasal in-situ gel. Iraqi J Pharm Sci. 2019;28(2):95–104.
Marzouk MA, Osman DA, Abd El-Fattah AI. Formulation and in vitro evaluation of a thermoreversible mucoadhesive nasal gel of itopride hydrochloride. Drug Dev Ind Pharm. 2018;44(11):1857–67.
Wibble T, Engström J, Verrecchia L, Pansell T. The effects of meclizine on motion sickness revisited. Br J Clin Pharmacol. 2020;86(8):1510–8.
Maltepe C, Koren G. The management of nausea and vomiting of pregnancy and hyperemesis gravidarum-a 2013 update. J Popul Ther Clin Pharmacol. 2013;20(2):184-92
Tateosian VS, Champagne K, Gan TJ. What is new in the battle against postoperative nausea and vomiting? Best Pract Res Clin Anaesthesiol. 2018;32(2):137-48.
Darwesh AY, El-Dahhan MS, Meshali MM. A new dual function orodissolvable/dispersible meclizine HCL tablet to challenge patient inconvenience: in vitro evaluation and in vivo assessment in human volunteers. Drug Deliv Transl Res. 2021;11(5):2209–23.
Qazi F, Shoaib MH, Yousuf RI, Siddiqui F, Nasiri MI, Ahmed K, et al. QbD-based Eudragit coated Meclizine HCl immediate and extended release multiparticulates: formulation, characterization and pharmacokinetic evaluation using HPLC-Fluorescence detection method. Sci Rep. 2020;10(1): 1476-65
Saokham P, Muankaew C, Jansook P, Loftsson T. Solubility of cyclodextrins and drug/cyclodextrin complexes. Molecules. 2018;23(5):1–15.
Hadi BM, Al-Khedairy EBH. Preparation and Characterization of Atorvastatin Calcium Trihydrate -cyclodextrin Inclusion Complex. Int J Drug Deliv Technol. 2022;12(3):1171–9.
Gupta MM, Patel Mitul G, Kedawat M. Enhancement of dissolution rate of rapidly dissolving oral film of meclizine hydrochloride by complexation of meclizine hydrochloride with β-cyclodextrine. J Appl Pharm Sci. 2011;1(9):150–3.
Sharma, Sanjay Kumar, Patel RP. Enhancing the solubility and dissolution rate of meclizine hydrochloride by inclusion complex. J Drug Deliv Ther. 2019;9(4):57–64.
Upendra C Galgatte, Pravin D Chaudhari. Development of Metoclopramide hydrochloride in situ gel: nasal delivery and pharmacokinetics in New Zealand rabbits. Asian J Pharm Clin Res. 2019;12(4):280–5.
Mahajan HS, Gattani S. In situ gels of metoclopramide hydrochloride for intranasal delivery: In vitro evaluation and in vivo pharmacokinetic study in rabbits. Drug Deliv. 2010;17(1):19–27.
Agrawal A, Maheshwari RK. Formulation development and evaluation of in situ nasal gel of poorly water soluble drug using mixed solvency concept. Asian J Pharm. 2011;5(3):131–40.
Malviya V. Design and characterization of thermosensitive mucoadhesive nasal gel for meclizine hydrochloride. International Journal of Pharmaceutical Sciences and Nanotechnology. 2022;15(1):5782-93.
George SJ, Vasudevan DT. Studies on the preparation, characterization, and solubility of 2-HP-β-cyclodextrin-meclizine HCl inclusion complexes. J Young Pharm. 2012;4(4):220–7.
Vemula SK, Vangala M. Formulation development and characterization of meclizine hydrochloride sublimated fast dissolving tablets. Int Sch Res Not. 2014;2014:1–8.
Palakurthi S, Kolluru S, Mehra N, Hidau M. Cyclodextrin complexation of meclizine hydrochloride and its influence on the solubility for its repurposing. Drug Deliv Lett. 2017;7(1):54–61.
Yang J, Ma Y, Luo Q, Liang Z, Lu P, Song F, et al. Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application. Eur. J. Pharm. Sci. 2022;168:106078.
Aloisio C, de Oliveira AG, Longhi M. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine. J. Pharm. Biomed. Anal. 2014;100:64-73.
Rao M, Agrawal DK, Shirsath C. Thermoreversible mucoadhesive in situ nasal gel for treatment of Parkinson’s disease. Drug Dev Ind Pharm. 2017;43(1):142–50.
Gu F, Fan H, Cong Z, Li S, Wang Y, Wu C. Preparation, characterization, and in vivo pharmaclokinetics of thermosensitive in situ nasal gel of donepezil hydrochloride. Acta Pharm. 2020;70(3):411–22.
Yurtdaş-Kırımlıoğlu G. A promising approach to design thermosensitive in situ gel based on solid dispersions of desloratadine with Kolliphor® 188 and Pluronic® F127. J Therm Anal Calorim. 2022;147(2):1307–27.
Naresh WR, Dilip DV, Sunil KP. Xyloglucan based Nasal in situ gel formulation of mirtazapine for treatment of depression. Indian J Pharm Educ Res. 2020;54(2):S210–9.
Thakkar H, Vaghela D, Patel BP. Brain targeted intranasal in-situ gelling spray of paroxetine: Formulation, characterization and in-vivo evaluation. J Drug Deliv Sci Technol. 2021;62:102317
Bhuva F, Patel LD. In-Situ Gelling for Prolonged Drug Delivery: Formulation and in-vitro evaluation of imidazole class drug. J Pharm Chem Biol Sci. 2018;6(4):292–304.
Corazza E, di Cagno MP, Bauer-Brandl A, Abruzzo A, Cerchiara T, Bigucci F, et al. Drug delivery to the brain: In situ gelling formulation enhances carbamazepine diffusion through nasal mucosa models with mucin. Eur J Pharm Sci. 2022;179:106294.
Thomas LM, Khasraghi AH, Saihood AH. Preparation and evaluation of lornoxicam in situ gelling liquid suppository. Drug Inven Today. 2018;10:1556–63.
Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, Xie S. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. The AAPS journal. 2010 Sep;12:263-71.
Nikolić VD, Ilić-Stojanović SS, Nikolić LB, Cakić MD, Zdravković AS, Kapor AJ, Popsavin MM. Photostability of piroxicam in the inclusion complex with 2-hydroxypropyl-β-cyclodextrin. Hem ind. 2014;68(1):107-16.
Singh RMP, Kumar A, Pathak K. Thermally triggered mucoadhesive in situ gel of loratadine: β-Cyclodextrin complex for nasal delivery. AAPS PharmSciTech. 2013;14(1):412–24.
Zarrintaj P, Jouyandeh M, Ganjali MR, Hadavand BS, Mozafari M, Sheiko SS, et al. Thermo-sensitive polymers in medicine: A review. Eur Polym J. 2019;117:402–23.
Abdel Bary G. Preparation and characterization of thermosensitive mucoadhesive in situ gels for nasal delivery of ondansetron hydrochloride. Al-Azhar J Pharm Sci. 2014;50(2):191–207.
Lakshmi P, Harini K. Design and optimization of thermo-reversible nasal in situ gel of atomoxetine hydrochloride using Taguchi orthogonal array design. Dhaka Univ J Pharm Sci. 2019;18(2):183–93.
Raheema DA, Kassab HJ. Preparation and in-vitro evaluation of secnidazole as periodontal in-situ gel for treatment of periodontal disease. Iraqi J. Pharm. Sci.. 2022;31(2):50-61.
Wang Y, Jiang S, Wang H, Bie H. A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases. PLoS One. 2017;12(12):1–17.
Pathan IB, More B. Formulation and characterization of intra nasal delivery of nortriptyline hydrochloride thermoreversible gelling system in treatment of depression. Acta Pharm Sci. 2017;55(2):35–44.
Godbole MD, There PW, Dangre P V. Formulation and optimization of prolonged release nasal in situ gel for treatment of migraine. Indo Am J Pharm Res. 2014;4(02):1320–32.
El Shagea HN, Makar RR, Salama AH, Elkasabgy NA, Basalious EB. Investigating the targeting power to brain tissues of intranasal rasagiline mesylate-loaded transferosomal in situ gel for efficient treatment of Parkinson’s disease. Pharmaceutics. 2023;15(2):533
Salunke SR, Patil SB. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration. Int J Biol Macromol. 2016;87:41–7.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
